Sarcomas, ASPHO Flashcards

1
Q

most imp somatic mutations in RMS?

A

PAX-FOX0O1 fusions in alv. RMS t(2;13)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common PAX_FOXO1 in RMS?

A

PAX3-FOXO1 (2;13) =60% >PAX7-FOXO1 (t;13)=20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PAX-FOXO1 mut is a ___ in tumorigenesis

A

driver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

give 2 genetic changes seen in fusion neg RMS

A

aneuploidy
activation muts of RAS pathway (FGF4, NRAS, KRAS, etc muts)
p53 muts= unfav
myoD muts= unfav
LOH or Loss of Imprinting at 11p15.5
NCOA2, VGLL2 rearrangements= fav in infants with spindle cell RMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give 5 germline muts associted with RMS

A
Li-Fraumeni=p53
BWS=IGF2
Costello=HRAS
Noonan= RAS-MAPK path
NF1= NF1
Gorlin= PTCH1
PBB= Dicer 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bimodal peak for general sarcomas adn soft tissue sarcomas?

A

infancy and teenage years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

presentation of RMS?

A

mass
+/- pain
+/- distrubance in function like CN palasy or bladder dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

most common site of RMS?

A

head and neck>GU>extrem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

favourable H&N site for RMS

A

orbit, non-parameningeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

parameningeal site= unfavourable in rhabdo…waht does this include?

A

base of skull, including infratemporal fossa, paranasal sinuses, parapharyngeal area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

favourable GU site for RMS?

A

paratsticular, vag, uterine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

unfavoruable GU site for rhabdo?

A

bladder, prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

lymphatic spread of RMS seen where?

A

paratesticular, extremity tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CNS ext seen where in RMS?

A

50% parameningeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hematogenous mets go where in RMS?

A

lung, bone, BM, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

stage RMS how?

A
  • MRI or Ct of priamry site adn regional nodal basin
  • CT chest
  • PET scan or bone scan
  • bilateral BMA/bx
  • CSF cytomology if parameningeal/paraspinal
  • LN for paratestictular at least 10 years of age or extremity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

WHich RMS pts do NOT need bone scan, BMA/bx, possible chest CT?

A

ERMS, T1, N0 disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what’s the name of the MRS staging system?

A

IRS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe stage 1 or IRS staging for RMS

A
  • favourable site: orbit, non-parameningieal head and neck, non-bladder/prosatate GU, biliary tract
  • T1= confined to site of origin or T2= extension and/or fixation to surroundign tissue
  • size: any
  • any regional LN status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe stage 2 for RMS staging

A
  • unfav site: parameningeal, bladder/prostate, extremity, other
  • T1 or T2 (same)
  • size <5 cm
  • regional lymph nodes not present or unknwon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

describe stage 3 for RMS

A
  • unfav site
  • T1 or T2 (same)
  • size: <5 cm if just regional LNs involved, vs. >5 cm for LNs not involved/regional involvement/unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

describe stage 4 RMS

A
  • all sites with distant mets
  • T1 or T2 (same)
  • any size
  • regional LNs involved or not
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what does RMS grouping tell you?

A

IRS grouping tells you extent of tumour remaining after SURGERY, before any other tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe RMS group 1

A

completely resected lcoal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe group 2 in RMS

A

gross total resection with evdience of regional spread…
A): microscopic residual diseae
b) reigonal nodes involved AND completely researcted
C) regional nodes invovled and grossly resected but have microscopic residual disease and histo involvement of the resected regional nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

describe group 3 rmS

A

incomplete resection with gross residual disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

describe gropu 4 RMS

A

distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what’s very prog in RMS?

A

staging= extent of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

3 yr FFS in stages 1-4 RMS?

A

86%
80%
68%
25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

how does group impact prog?

A

Groups1-3 have better 5-yr FFS and 5-yr OS (73% and 84%) than group 4 (30% and 42%)…..also 3-yr FFS gets worse with higher group: 83%->86%->73%->25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

RMS histo subtypes in fusion neg?

A

spiondle cell, botryoid, embryonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what if you are fusion negative but alveolar RMS?

A

better prog, simialr to embryonal histo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

describe RMS risk gruops (COG)

A

low risk has a 5 yr FFS of at lesat 85%…drops to 50-75% for intermed and 20% or less for high…to be low risk, must be stage 1-2 with group I-II diseaes, embryonal OR stage 1, group III ORBIT, embryonal….high risk: stage 4, group 4, at lesat 10 yrs of age with emrbryonal or stage 4+ group 4 wtih alv. RMS (fusion pos)…everything else= intermed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

primary site in RMS = prognostic. best site? worst site? order?

A

best= orbit/head and neck
worst= extremity
order. orbit/head and neck>GU non-bladder/prostate> then GU ballder/prostate, parameningeal>other>extremity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

other than primary site, genetic mutations, staging, group, what else is prog in RMS?

A
  • mets…mets to lung better than to bone/bone marrow.
  • and # of met sites…2 or less is better than 3 or more!
  • recurrence…~20-25% 3-5 yr OS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

if relapsed RMS, waht are good RFs?

A

botryoid histology

ERMS that was stage 1 or group 1 at initial dx with local or regional recurrence adn not previously tx’ed iwth cyclophos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what are 3 main types of childhood RMS

A

embryonal, alveolar, spindle cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

ERMS and spindel cell RMS fall in teh category of ___ ___ tumours; what else is in this category?

A

spindle cell; synovial sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

how can you differentiate synovial sarcoma from RMS (ERMS or spindle cell RMS)?

A

ERMS and spindle cell RMS: pos for MyoD, myogenin, Desmin, muscle specific actin…but synovial: cytokeratin, EMA, Bcl2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

ARMS falls in teh category of what tumours?

A

Small round blue cell tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

small round blue cell tumour pos for NSE, synaptophysin, TH, PHOX2b?

A

NBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

small round blue cell tumour + for CD99, vimentin, +/-NSE, synaptophysin?

A

EWS/PNET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

SRBC tumour + for myoD, myogenin, desmin, muscle specific actin?

A

ALVEOLAR RMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

SRBCT pos for LCA< CD3, CD20, TdT?

A

lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

most common type of RMS?

A

embryonal, ~2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

ERMS has includes a ___ pattern

A

botryoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

ERMS associated with a ___ age, ___ site, ___ disease, ___ prog

A

younger; favourable; localized; favourable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

spindle cell RMS: associated with ___ or ___ rearrangements in infants and a ___ prog

A

NCOA2; VGLL2; favourable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what % of alv RMS is fusion neg?

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

RMS tx involves? broadly

A

surgery, radiotherpay, chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

tx in RMS based on?

A

risk groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

RMS risk groups based on what things? 4

A

stage
group
histo/fusion status
age (soemtimes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

surgical approach in RMS?

A

excise pirmary tumour upfront whenever possible wihtout –> major functional or consmetic defs…sometimes wait to do surgery if think may spare radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

which RMS sites reqwuire surg assessmetn of LNs?

A

paratesticular (retroperitoneal for boys 10 yrs+), extremity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

who doesn’t need rads in RMS?

A

group 1 ERMS/spindle cell RMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

do radiation when in RMS?

A

usually begins during week 3-15 of therpay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

dose of rads in RMS

A

36-50.4 Gy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Standard= interm risk chemo in RMS?

A

VAC x 45 weeks = vcr, dactinomycin, cyclophos

59
Q

low risk chemo in RMS?

A

VA…or shorter duration with VA + lower CPM dose

60
Q

high risk chemo in RMS?

A

no standards…can add doxo, epto, ifos, irinotecan

61
Q

image how often in RMS?

A

q3 months

62
Q

response at 12 weeks: predictive of survival in RMS?

A

no

63
Q

aucte tox in RMS?

A

heme tox, infection, VOD with dactinomyicn and cyclophos

64
Q

late effects of RMS?

A

infert due to alk agents 7.5-8 mg/m2 esp in boys (standard dose and higher)…secondary maligs due to alk agents/radiation/CPS…bone growth/arrest/muscle atrophy due to radiation

65
Q

non rhabdo soft tissue: tend to occur where? spread wehre?

A

extremities, trunk….lungs, bone, LNs

66
Q

general work up for non rhabdo soft tissue tumours?

A

MR/Ct of primary, Ct chest, PET scan, nodal eval for select tumorus

67
Q

non rhabdo soft tissue sarcomas: prog depends on?

A

stage, group (extent of resection), tumouor size (< or >5 cm), grade (mitotic rate), tumour type, age

68
Q

ilst 3 non-rhabdo soft tissue sarcomas that are reposneive to chemo

A

synovial, undifferentatied, infantile fibrosarcoma

69
Q

most common non-rhabdo soft tissue sarc?

A

synovial

70
Q

transloc in synovial sarc?

A

t(X;18) SYT-SSX

71
Q

tranlsoc seen in infantile fibrosarcoma?

A

t(12;15)= ETV-NTRK3 fusion…most common STS in children <1 yrs…give VA, VAC, or larotectinib if not resected

72
Q

3 non rhabdo soft tissue sarcs that are poorly responsive to chemo

A

MPNST, leiomyosarcoma, alveolar soft part sarcoma, epithelioid sarcoma

73
Q

MPSNT asscoiated with what CPS?

A

NF1

74
Q

sarcoma associated with immunosuppression and HIV?

A

leiomyosarcoma

75
Q

fusion seen in alv soft part sarcoma?

A

t(X;17) = ASPSCR1-TFE3 fusion

76
Q

non rhabdo STS: tx philopshy?

A

surgery + radiotherpay….+/- chemo

77
Q

general tx approach in nrSTS?

A

based on extent of resection…group 1: observe unless grade 3 or large, then do RT (and maybe chemo= doxo + ifos)….group 2: RT alone unless grade 3 or large, then consdier chemo (Doxo + ifos)…group 3-4: RT, delayed surgery, consider chemo

78
Q

what’s being investigated in NRSTS?

A

pazopanib= tki

79
Q

give 2 cytogen changes seen in osteosarcoma

A

chromothripsis

supernumary ring chromosone 12q13-15

80
Q

3 molecular abnoramliteis seen in osteosarcoma

A

Rb, p53, RECQL4 helicase mutations (germline)

81
Q

peak age for osteo?

A

~15

82
Q

3 rfs for osteo?

A

ionizing rad, hereditary rb, li fraumeni

83
Q

presentation of oseto?

A

pain +/- mass invovlign metasphyses of long bone

84
Q

3 most common primary sites in osteo?

A

distal femur> prox tibia>prox humerus

85
Q

what is a skip lesion?

A

pattern of spread of osteo; can be several cm from primary, in the same bone…occurs in 20% of osteo

86
Q

how does osteo spread?

A

skip lesions adn hematgenous spread

87
Q

sites of osteo mets? (2)

A

lung>bone

88
Q

what % of osteo has mets at dx?

A

15-20%

89
Q

stage osteo how?

A

plain films of primary
MRI of primary
CT chest
PET scan or bone scan

90
Q

stage assginemnt in osteo based on waht two things?

A

localized or not

resectable or not

91
Q

localized osteo 3 yrs EFS?

A

65-70%

92
Q

5 yrs EFS in met osteo?

A

<30%

93
Q

in osteo, bettter to have unilateral pulm mets or bone mets?

A

unilateral pulm mets

94
Q

describe role of necrosis in osteo

A

if at lesat 90% necrosis at 10 week of pre-op chemo, better 3-yr EFS…80% vs 60%

95
Q

types of histo that are favorable in osteo?

A

parosteal, fibroblastic, telangiectatic

96
Q

how does lcoation and size play a role in osteo prog?

A

extremity better than axial; 8 cm or less better

97
Q

relapsed osteo don’t do well. RFs for shorter survival after realpse?

A

age >10
mets at dx
lung and bone recurrence
time to relapse<2 yrs

98
Q

pathognomic features on histo for osteo?

A

osteoid-producing malig cdells

99
Q

2 major histo subtypes of osteo?

A

central (medullary) and surface tumours

100
Q
for the following types of OS, indicate if central=medullary or surface
1-small round cell
2-low grade central
3-parosteal
4-telangiectatatic
5-conventional
6-periosteal
7-high grade surface
A
1-central
2-central
3-surface
4-central
5-central
6-surface
7-surface
101
Q

3 features of osteo on x-ray?

A
  • mixed osteoblatsic+ oteolytic features
  • cortical destruction adn expanstion into soft tissue
  • periosteal reaction, eg: codman triagle, sunburst pattern
102
Q

ewings is more ___ than osteo

A

osteolytic

103
Q

5 ddx for osteosarcoma?

A
ewing sarcoma
mets
LCH
oseomyelitis
osteoblastoma
aneurysmal bone cyst
fibrous dysplasia
104
Q

tx philosophy for osteo?

A

SURGICAL resection of all gross tumour adn chemo

105
Q

timing of surgery in osteosarcoma?

A

after 10 weeks of neoadj chemo

106
Q

advanrages of neoadj chemo in osteo?

A
  • allows starting therapy more rapidly
  • may faciliate limb salvage surgery
  • provides histo response
107
Q

chemo in osteo?

A

HD-Mtx, doxo, cisplatin= MAP

108
Q

what type of osteo doesn’t need chemo?

A

PAROSTEAL

109
Q

what’s teh diff between parosteal and periosteal osteosarcom?

A

parosteal: tends to occur in distal femur, is low grade, reqwuires resection only!
periosteal: tends to occur at prox tibia, is intemdiate grade, tx with resection +/-chemo

110
Q

3 things you may see on imaging that indicate osteo improving?

A
  • increased ossification
  • sclerosis or calcification or border
  • reduction in soft tissue mass
111
Q

late effects in osteo?

A

cardiomyopathy (athracyclin)…in >20%

cisplatin-indcued ototox

112
Q

most common fusion in EWS?

A

EWSR-FLI1 fusion = t(11;22), 85%!

113
Q

2nd most common EWS fusion?and another?

A

21;22…2;22

114
Q

detect EWS transloc how?

A

RT PCR or FISH

115
Q

EWS: more common in black or white pts?

A

white

116
Q

presenation of EWS?

A

pain +/- palp mass

117
Q

EWS: what part of bone involved?

A

diaphyses and central axis

118
Q

most common site in EWS (3)

A

pelvis>femur>rib

119
Q

top 3 met sites in EWS?

A

lung>bone>BM

120
Q

what % of EWS have mets?

A

20%…same as osteo

121
Q

EWS staging how?

A
plain films
MRI or CT of primary
CT chest
PET or bone scan
bilateral BMA/bx
122
Q

assign stage how in EWS?

A

local vs mets

123
Q

most imp prog featuers in EWS?

A

stage

124
Q

in terms of prog, worst primary site in EWS?

A

pelvis

125
Q

describe how tumour size and age are import in EWS prog

A

better if younger

better if <8 cm

126
Q

2 stains used in EWS?

A

CD99, vimentin

127
Q

EWS can have differentaition or not…if does have diff, see what? (3)

A

rosettes
NSE
synaptophysin

128
Q

what features of EWS are seen on x-ray?

A

lytic lesion with a wide zone of transition and periosteal reaction…see aggressive periosteal reactions like codman triangle, sunburst pattern or onion skin pattern

129
Q

ddx for EWS on x-ray?

A

osteosarcoma, mets, LCH, osteomyelitis

130
Q

tx philosophy for EWS?

A

surg, radiation, neoadj chemo, (SCT)…use surg when possible

131
Q

tx in EWS based on what 2 things?

A

stage, site

132
Q

rad dose in EWS?

A

36-50.4 Gy

133
Q

chemo in EWS?

A

VDC IE= vcr, doxo, cyclo, ifos, etop

134
Q

other htan VDC IE, what are other active agents in EWS?

A

topotecan, iriontecan, temozolomide

135
Q

role of SCT in EWS?

A

possibly for high risk localized EWS

136
Q

late effects in EWS?

A

Radiation: –> SMNs (carcinomas, sarcomas, 10%); path fractures/limb length discrepancy/femoral head necrosis..
Chemo: leukemias, cardiomyopathy from athracyclin, ifosfamide-induced nephrotoxicity = dose-dep proximal tubular damage

137
Q

BRIEFLY describe bio of RMS vs NRSTS vs OS vs EWS

A
ERMS: aneuploidy, point mutations
ARMS: PAX-FOXO1 fusions
NRSTS: many tumour types
OS: chrom instability
EWS: TET-ETS fusion: EWSR1-FL1
138
Q

most common sites for RMS/NRSTS/OS/EWS?

A

RMS: head, GU tract
NRSTS: extrems, trunk
OS: metaphyseal, distal femur adn prox tibia
EWS: diaphyseal or soft tissue, pelvis and central axis most common

139
Q

risk based on what for RMS/NRSTS/OS/EWS?

A

RMS: stage, group, fusion status, histo
NRSTS: stage, group, tumour size, grade, histo
OS: stage, resectability
EWS: stage, site

140
Q

histo of RMS/OS/EWS?

A
ERMS: spindle cell tumour
ARMS: SRBCT
RMS in general: myogenin, desmin +
OS: osteoid-producing malig cells
EWS: SRBCT, CD99+, may show neural diff
141
Q

tx in RMS?

A

upfront surgery +/- delayed RT/surgery…systemic= VAC +/- VI

142
Q

tx in NRSTS?

A

local: surgery (may be dleayed) +/- RT (may be pre-op)…systemic= +/- Doxo, ifos depending on chemo sens

143
Q

tx in OS?

A
local= delaeyd surgery
syst= MAP
144
Q

EWS tx?

A
local= delayed surgery adn/or RT
syst= VDC/IE